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ABSTRACT
FAILURE OF OPIOIDS TO MODIFY NORADRENERGIC
NEURONAL RECOVERY FROM A DORSAL BUNDLE LESION
IN NEONATAL RATS
by
Ellen Kunkel Bagden
Morphine and exogenous opioid peptides alter the
development of central noradrenergic neurons damaged by
neonatal treatment with the neurotoxin 6-hydroxydopa.
Transection of the dorsal noradrenergic bundle (DNB) in
neonatal rats produces nearly the same alteration in the
developmental pattern. It was of interest to determine
whether morphine or an exogenous opioid peptide (metenkephalin) was able to modify the recovery of noradrenergic
neurons after neonatal surgical transection of the DNB.
Neonatal rats were divided into two groups. Both groups
received saline (0.85%) or naloxone (2.0 mg/kg) by the
intraperitoneal (i.p.) route. In the first group the
animals received an additional i.p. injection of either
saline or morphine sulfate (3.33 mg/kg). The second group
received an intraventricular injection of either saline,
morphine (10 ug/5 pi), or methionine-enkephalin (25 pg/
5 yl) ten minutes after the i.p. injection. Half the
animals in these groups then received a DNB lesion, made
with a blade 3mm (depth) by 5mm (width) at the level of
the colliculi. At 6 weeks brains were removed for assay
of norepinephrine (NE) content by a fluorometric method,
and for determination of the rate of H-NE uptake, in
order to assess noradrenergic fiber number. It was found
that in the cerebellum both the H-NE uptake rate and NE
content were significantly elevated by approximately 75%
in the animals that received the lesion. The recovery in
the anterior cortex (39%) was significantly greater than
in the posterior cortex (27%), while recovery in the
hippocampus (21%) was the least. This indicates a regional
difference in recovery in the more distal projections of
the DNB. Within the lesion group, however, there was no
alteration in H-NE uptake rate nor NE content in any of
the above regions with any of the drug treatments.
Therefore, none of the drug treatments effectively altered
the recovery from surgical transection of the DNB. It is
suggested that opioids are capable of modifying neurotoxin
damage per se, but not capable of modifying regeneration
of noradrenergic neurons.
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Chapter I
Historical Review

A.

Introduction
The noradrenergic (HA) neuronal pathways in the

central nervous system (CHS) have been well mapped and are
known to extensively innervate virtually all major structures
of the brain and spinal cord.

One of the most common means

of studying the distribution of this fiber network is the
destructive elimination of portions of the pathways,
followed by subsequent histochemical/biochemical mapping
in the experimental and control groups.

Removal of HA

fibers can be brought about by administration of relatively
selective neurotoxins such as 6-hydroxydopamine (6-OHDA) or
6-hydroxydopa (6-0HD0PA), or by mechanical transection of
the fiber bundles.
In order to gain insights into the ontogenic development
of the above system, the indicated procedures are often
carried out in immature animals.

Because of the growing

body of evidence that opioids interact with the HA system
in a variety of ways, it is considered to be of value to
determine how opioids might alter the developmental
recovery of the HA system after a mechanical injury to one
of the major fiber bundles.
B.

Projections of the Locus Coeruleus
The locus coeruleus, a compact pontine nucleus located
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in the central gray of the isthmus, is comprised of about
1500 cells which project axons throughout the CNS.

The

largest fiber projection of this nucleus is the dorsal
noradrenergic bundle (DNB), which transmits axons to
many forebrain regions.

This compact bundle joins the

medial forebrain bundle, and ascends rostrally in the
brain to the genu of the corpus callosum, whereupon it
diverges into a highly collateralized network (Moore and
Bloom, 1979).

The fibers of the DNB terminate in the

cerebral cortex, hippocampus, thalamus, geniculate bodies,
colliculi, habenula, some dorsal hypothalamic nuclei, and
olfactory bulb (see Jacobowitz, 1978).

The locus coeruleus

also provides fibers which innervate virtually all segments
of the spinal cord, distributing widely to both dorsal and
ventral horns.

Projections from the coeruleus have

additionally been demonstrated in the brainstem,
predominantly to the sensory nuclei.

A third area to which

the locus coeruleus projects is the cerebellum.

In this

brain region a sparse input to the granule cell layer is
noted, along with an extensive innervation of the Purkinje
cells and molecular layer (Moore and Bloom, 1979).
In the rat the cells of the locus coeruleus
differentiate between fetal days 10 and 13.

The fiber

connections to all the target areas of the nucleus have
been made by birth (Lauder and Bloom, 1974), although the
target areas per se may develop later.

Groups of neurons

in the locus coeruleus are known to be divergent, i.e., a

single neuron projects axons to two or more regions in the
CNS, such as to the cerebellum and spinal cord; or the
frontal cortex and cerebellum; or the neocortex and
hippocampus; etc.

(Steindler, 1981; Room et al., 1981;

and Ader et al., 1980).

Steindler (1981) estimated that

in mice 6% of the locus coeruleus cells that project to the
neocortex also provide collateral fibers to the cerebellum.
Conversely, 61% of the cells that project to the cerebellum
were found to have collaterals to the neocortex.

The fiber

projections to the cerebral cortex from the nucleus are of
two types.

The most common fiber type innervates a

restricted region, while the other innervation is wide
spread to various areas of the cortex (Nagai et al., 1981).
C.

Destruction of the Noradrenergic Fiber Pathways
Several methods are available to alter the pattern

of distribution of the fiber projections from the locus
coeruleus.

Administration of 6-OHDA or 6-OHDOPA to neonatal

rats during the first two weeks after birth results in de
generation of NA fibers.

This is followed by a permanent

hyperinnervation by central NA neurons in the pons-medulla,
mesencephalon, and cerebellum, when treatment is prior to the
fourth postnatal day.

In contrast the NA input to forebrain

regions remains permanently reduced after such treatment
(Breese and Traylor, 1970; Jonsson et al., 1974; Zieher
and Jaim-Etchevery, 1975; Pappas and Sobrian, 1972;
and Kostrzewa and Garey, 1976).

The principal nucleus

involved in this alteration of NA inputs is the locus
coeruleus, and it is this nucleus that is associated with
the major portion of NA sprouting or hyperinnervation
(Schmidt and Bhatnagar, 1979).

The result of neonatal

neurotoxin treatment is a reduction in NA input to the
forebrain regions accompanied by an elevation in the NA
input to the hindbrain regions.
Neonatal surgical transection of the DNB produces
nearly the same alteration in developmental pattern as
neurotoxin treatment.

Kostrzewa et al. (1985) found that

a brainstem lesion/ encompassing both dorsal noradrenergic
bundles, in neonatal rats between postnatal days 1 and 7,
produces significant alterations in the adult pattern of
NA fiber distribution.

As a result of this neonatal lesion

animals develop into adulthood with a significant decrease
in norepinephrine (NE) content and fluorescent NA fiber
density (with the glyoxylic acid technique) in the cerebral
cortex and hippocampus, but with an increase in these
parameters in the pons-medulla and cerebellum.

Jonsson

and Sachs (1982), using either a bilateral lesion as above
or a unilateral transection of the DNB, noted similar
developmental changes.
ed levels of NE,

The animals as adults have decreas-

H-NE uptake, and fluorescent fiber number

in the cerebral cortex, and a corresponding increase in
these parameters in the mesencephalon, pons-medulla, and
cerebellum.
These alterations in NA input, demonstrated with neuro

toxin treatment and transection of the DNB, have been
explained by Jonsson and Sachs (1962) and Jonsson and
Hallman (198 2b) as due to the so-called Mpruning effect."
In this theory neurons are said to be programmed to form a
defined quantity of nerve terminals.

If one branch is

prevented from growing then a compensatory outgrowth will
take place in the intact branches proximal to the lesion.
As stated previously the pattern of recovery is almost
identical for neurotoxin treated and surgically axotomized
animals, but the changes are less pronounced in surgically
altered animals.

However, the method of denervation of

each of these techniques is uniquely distinct.

The

surgical lesion affects only the DNB, while neurotoxin
treatment results in at least a partial denervation of
virtually all NA terminal areas.

The surgical lesion, by

damaging the major ascending axonal fibers, results in
degeneration distal to the cut.

The brainstem lesion also

severs blood vessels, other nerve fibers, and damages the
parenchymal tissue, while the neurotoxin destroys princi
pally NA fibers.
D.

Opioids
Recent evidence indicates that opioid peptide-

containing neurons are an integral part of the CNS.

These

neurons contain as neuromodulators or neurotransmitters
endogenous peptides, which are part of the opioid families
of enkephalins, endorphins, and dynorphins.

The neurons

have been mapped by immunohistochemistry and their respective
nuclei and patterns of distribution are different from each
other (Cuello, 1983 and Bloom, 1983).
The enkephalins are formed from enzymatic cleavage of
a prohormone.

Methionine-enkephalin (met-enkephalin),

specifically, is a pentapeptide (Tyr-Gly-Gly-Phe-Met)
formed by cleavage of proenkephalin-A (Morley, 1983).
Enkephalins can be released by electrical or high potassium
induced stimulation.

These peptides are inactivated by the

cerebral peptidases, aminopeptidase and enkephalinase
(Hughes, 1983).

The concentration of met-enkephalin is

higher throughout the brain than that of the other
enkephalin, leucine-enkephalin.
highest levels of met-enkephalin.

The striatum has the
Of the areas under

study high levels of met-enkephalin are found in the
pons-medulla, lower levels are detected in the cortex and
hippocampus, and the lowest levels are present in the cere
bellum (Cuello, 1983 and Yang et al., 1977).

Enkephalin-

immunoreactive nerve fibers are known to innervate the
source nuclei of all three major monoamine systems:

the

substantia nigra, the locus coeruleus, and the raphe
nuclei (Bloom, 1983).
Tsang et al. (1982) found that the highest postnatal
developing levels of enkephalin and its binding sites were
obtained within the first week for the cerebellum, during
the second week in the brainstem, and in the third week
within the forebrain and cerebral cortex.

Recently the interaction of the enkephalinergic neurons
with NA neurons has been studied.

Bloom (1983) noted that

enkephalin-immunoreactive fibers innervate the locus
coeruleus and the presence of opioid receptors in the
coeruleus has been known for several years.

Enkephalin-

containing fibers have also been identified in all brain
regions to which the locus coeruleus projects.
E.

Opioids in Combination with Neurotoxins
The locus coeruleus perikarya are known to receive

several inputs.

The enkephalinergic input described earlier

is considered to be an inhibitory one (Aghajanian and
Cedarbaum, 1979).

A substance P neuronal input onto

the locus coeruleus cells is considered to be excitatory.
Several authors have found that morphine and the
endogenous opioids potentiate the effects of neonatal
treatment with 6-OHDA and 6-0HD0PA.

Harston et al. (1981)

demonstrated that treatment with morphine or naloxone in
combination with 6-0HD0PA at birth results in increased
adult NE levels and numbers of NA fibers in the ponsmedulla and cerebellum.

Similar effects were seen with

8-endorphin, leu- and met-enkephalin, and d-ala enkephalinamide.

It was later shown that the morphine and

6-0HD0PA combination at 3 days after birth resulted in a
duplication of the findings from treatment at birth, with
the exception that now the changes were blocked by naloxone,
also given at 3 days after birth (Kostrzewa and Xlisans-

Fuenmayor, 1984).

Jonsson and Hallman (1982a) conducted

similar studies, administering 6-OHDA and morphine to
newborn pups.

The

H-NE uptake velocity in these animals,

as adults, was significantly reduced in the olfactory bulb
and frontal cortex and significantly increased in the
cerebellum.
of morphine.

Naloxone administration reversed the effects
Clonidine, another potent inhibitor of locus

coeruleus activity, administered as above in combination
with 6-OHDA, produced results similar to that of morphine
(Bardo et al., 1983).

Thus, opioids and other compounds

that inhibit locus coeruleus activity potentiate the
decreased NA fiber density in the forebrain, and the
increased fiber number in the hindbrain following neonatal
neurotoxin treatment.
Substance P, the peptide with excitatory effects on
locus coeruleus activity, counteracts the actions produced
by 6-OHDA (Jonsson and Hallman, 1982c and 1982d). When
substance P and 6-OHDA were administered at birth, the
adult NE levels and

H-NE uptake rate were increased in the

frontal and occipital cortex and decreased in the cerebellum
and pons-medulla.

Results similar to these have been found

with nicotine, a drug also known to alter locus coeruleus
activity (Jonsson and Hallman, 1980).
Bardo et al. (1983) and Harston et al, (1981) suggest
ed that the drugs which alter the response of the locus
coeruleus neurons, do so by modifying or enhancing the
degenerative response to the neurotoxins; that is, morphine

increases the toxicity of 6-0HD0PA and thus potentiates the
response of neurons.

Another explanation of the opioid

effects is the "pruning" hypothesis (Jonsson and Hallman/
1982a and 1982c and Harston et al., 1982).

According to

this hypothesis, synaptic inputs onto the locus coeruleus
govern the state of the nuclei at the time of treatment,
allowing an altered response to the neurotoxins.

The inter

action of opioids with NA fiber development is better
studied in animals where the NA network has been disrupted
by a mechanical (non-chemical) means.

With this technique

there are no drug interactions to complicate the study.
This type of damage will produce true pruning; that is, the
cutting of one branch of fibers produces an outgrowth of
the other branches.

In contrast the neurotoxin treatment

damages fibers throughout the brain, and this results in an
outgrowth of some of these fibers.

The present study thus

represents a novel approach to define the role of opioid
alteration of NA fiber recovery.

Chapter II
Preliminary Studies

To ascertain the feasibility of the present study
preliminary work was done.

Rats received a bilateral

lesion at the level of the colliculi at 3 days of age to
transect the dorsal NA bundles.

Immediately prior to the

cut animals received an injection of saline, morphine,
naloxone, or a combination of morphine and naloxone.

At

six weeks of age the NE content was determined in the
cerebellum, pons-medulla, hippocampus, and posterior
cortex.

It was found that animals receiving the neonatal

lesions had significantly lower NE levels in the hippocampus
and posterior cortex, and higher levels in the pons-medulla
and cerebellum.

Morphine treatment appeared to attenuate

this effect in the pons-medulla and cerebellum, while the
effect of naloxone was unclear.

In contrast the NE concen

tration in the posterior cortex and hippocampus was
significantly increased with morphine treatment.

Naloxone

administered alone did not vary the NE levels in these areas,
but it reversed the effects of morphine.

In this preliminary

study morphine treatment in combination with a brainstem
lesion significantly enhanced recovery of NE in the forebrain.
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CHAPTER III
Objectives and Proposal

This project is designed to determine whether opioids,
specifically morphine and met-enkephalin, alter the pattern
of distribution of noradrenergic fibers in specific brain
regions, subsequent to a gross surgical lesion encompassing
the DNB.

The hypothesis is that the opioid system does play

a role in regeneration of noradrenergic fibers after a
surgical lesion in the brainstem of developing animals.
To demonstrate the effects of morphine and enkephalin on
noradrenergic regeneration, measurements indicative of
noradrenergic fiber number will be made in different brain
regions of adult animals that were treated as neonates.
Comparison of the test subjects with sham controls will
provide the test of the hypothesis.
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CHAPTER IV
Materials and Methods

A.

Animals and Treatment
Animals from our colony of Camm-derived Sprague

Dawley rats were used.

Two groups of animals were treated

at 3 days after birth.

In the first group naloxone*HC1

{2.0 mg/kg) was administered concurrently with saline
(0.85%) or morphine sulfate (3.33 mg/kg) by the intraperitoneal (i.p.) route (table 1).

A second group of rats

received an i.p. injection of naloxone or saline, 10
minutes prior to an intraventricular (i.vtr.) injection of
5 vl of morphine sulfate (10 yg), or methionine-enkephalin
(25 ug# Behring Diagnostics)# or saline (0.85%) (table 1).
Half the animals treated with the above regimens
received a surgical lesion, made with a blade 3 mm (depth)
by 5 mm (width) under ice anesthesia (80 seconds), at the
level of the colliculi, as illustrated below:

forebra:

lambda
cerebellui
5mm width

3mm depth

12
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Group 1
i.p.

Group 2
A-P-

i*P *

i.vtr.

Saline

+

Saline

Saline

+

Saline

Saline

+

Morphine

Saline

+

Morphine

Naloxone

+

Saline

Saline

+

Met-Enk

Naloxone

+

Morphine

Naloxone

+

Saline

Naloxone

+

Morphine

Naloxone

+

Met-Enk

Table 1

Animals listed In group 1 received a combination of
two intraperltoneal (I.p.) Injections of saline, morphine,
or naloxone, as Indicated.

Animals in group 2 were

injected with naloxone or saline (i.p.), 10 minutes prior
to an intraventricular (i.vtr.) injection of saline,
morphine, or met-enkephalin (met-enk), also in the
combinations indicated.
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The remaining half of the animals were anesthetized on ice,
but did not receive the surgical lesion.

The animals in

group 1 received one of the injection combinations
immediately following the surgical lesion.

In the second

group, animals received the i.p. injection 10 minutes prior
to the i.vtr. injection, and were surgically lesioned
immediately afterward.
Following treatment, litters were returned to their
dams and kept in the animal care facilities on a 12 hour
light/dark day cycle (on 0600) until sacrifice.

The pups

were weaned at 4 weeks, at which time the males and females
were separated for group housing.

All animals were sacri

ficed at 6 weeks of age unless otherwise indicated.
B.

Histochemistry
Noradrenergic fibers were observed histochemically

with the glyoxylic acid histofluorescence method of de la
Torre and Surgeon (1976).

In this procedure the whole

brain was removed, mounted, and frozen onto a specimen
plate.

The tissue was then cut in cross sections at

30 ym in an IEC cryostat.

Sectioned tissue from the cortex

was then thawed onto glass slides and immersed in a glyoxylic
acid solution (1%) containing sucrose (0.2 M) and potassium
phosphate (0.236 M). After drying the tissue specimens
were heated to 80°C for exactly 5 minutes, after which, the
slides were coverslipped with mineral oil. Sections were
viewed in an Olympus fluorescence microscope by two

15
experienced observers, who were unaware of the treatment
grouping of each animal, After observation for green
fluorescent fibers, photomicrographs were taken for a
permanent record of the observation.
C.

Determination of NE Concentration
Biochemical assessment of NA fiber input to the

various brain regions was made with the trihydroxyindole
fluorometric method of Hogans (Nagatsu, 1973).

The

cerebellum, pons-medulla, anterior cortex, posterior cortex,
and hippocampus were dissected at the time of sacrifice,
frozen on dry ice, and stored at -80°C until the time of
assay.

Dsing this procedure, tissues were homogenized in

acidified butanol, and HE was extracted into a phosphate
buffer (pH 6.5), for oxidation to the product, 3,5,6trihydroxyindole, by iodine.

The relative amount of

fluorescent product was then determined in a spectrophotofluorometer at 385/485 (excitation (nm)/emission (nm))
wavelengths.

The concentration of NE was expressed as

nanograms NE per milligram tissue mass.
D.

Measurement of ^H-Norepinephrine Optake Rate
The anterior cortex, posterior cortex, and cerebellum

were dissected at the time of sacrifice and immediately
homogenized on ice in 10 volumes (weight/volume) of 0.32 M
sucrose.

The homogenate was then centrifuged at 1,000 x g

for 10 minutes to obtain the supernatent containing synaptosomes (Jonsson and Sachs, 1976).

Analysis of protein

content was done on an aliquot of supernatent (Lowry et al.,
(1951).

Aliquots of the supernatent (125 pi of posterior

cortex or anterior cortex and 160 yl of cerebellum) were
preincubated for exactly 5 minutes at 37°C with Krebs-Ringer
bicarbonate in a total volume of 1.9 ml (pH 7.4 with 0.2
mg/ml ascorbic acid, 2.41 yg/ml nialamide and saturated
with 95% 0^ and 5% C02),

After addition of 0.1 ml of a

3H-NE (10 yCi/ml of DL-[7-3H(N)] NE-HC1) and NE*HC1
(0.05 ym for posterior cortex or anterior cortex and
0.1 ym for cerebellum) solution, incubation was continued
for another 5 minutes.

The 3H-NE uptake process was

terminated by addition of 8 ml of cold Krebs-Ringer buffer.
Samples were spun at 10,000 x g for 10 minutes and the
supernatent was discarded.

Absolute ethanol (1.2 ml) was

added and the samples were allowed to stand overnight.

The

next day 1 ml of the ethanol containing the extracted radio
activity was counted in 10 ml scintillation fluid
(Scintiverse, Fischer) using a Beckman liquid scintillation
counter.

The fmoles NE taken up was calculated by dividing

the DPM's by the specific activity of the 3h -NE solution.
E.

Radioimmunoassay of Met-Enkephalin
A separate group of animals was surgically lesioned,

as described earlier, at 3 days and sacrificed at 4 or 7
days after birth.

During the dissection the pons-medulla,

a portion of the pons-medulla containing the locus coeruleus,
and the posterior cortex was removed.

This tissue was then
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stored at -80°C until time of assay.
Tissue was then weighed and heated in 1 M acetic acid
(200 pi for locus coeruleus and 700 yl for pons-medulla and
posterior cortex) at 95°C for 15 minutes.

The samples were

chilled^ homogenized by ultrasound (Branson Model W-200 P)
for 5 seconds/ and after removal of an aliquot for
protein, were centrifuged at 1,000 x g for 10 minutes.

The

supernatent was transfered to microfuge tubes and vacuum
centrifuged until dry.

The samples were resuspended in

500 yl of BSA-phosphate buffer with ultra-sound for 5 seconds,
followed by shaking at 37° for 10 minutes.

After centri

fugation at 10,000 x g each aliquot was appropriately
diluted with buffer.

Met-enkephalin content was measured

using a radioimmunoassay (RIA) kit from Immuno Nuclear
Corporation.
P.

Statistical Analysis
A 2 x 4 ANOVA was done using the NG content and

3'

H-NE uptake values for the systemic administration of

opioids.

A 2 x 6 ANOVA was used for the data obtained

after intraventricular administration of drugs.

A single

factor ANOVA and then a Newman-Keuls was used to analyze
the per cent recovery in the anterior cortex, posterior
cortex, and hippocampus.

A single factor ANOVA was also

used to compare met-enkephalin content in control and
lesioned animals in the different areas studied.

Chapter V
Results

A.

Verification of Transection of the Dorsal Bundle
Control and experimental animals receiving a lesion

at 3 days postnatally were sacrificed at 7 days after birth.
At this time there was no gross evidence of the lesion.
However, using the histofluorescence method large numbers
of brightly fluorescent, swollen and densely packed fibers
were seen emanating in a rostral direction from the locus
coeruleus of the animal receiving a lesion (fig. la).

This

contrasted sharply to the fine thin fibrils in the same
position in control animals (fig. lb).

It is generally

considered that the densely packed fluorescence indicates
a retrograde accumulation of NE in portions of axonal
fibers that are proximal to the transection.

B.

Systemic Administration of Morphine
In figure 2 the NE concentration and rate of ^H-NE

taken up in the cerebellum is reported.

The neonatal mid

brain lesion resulted, at six weeks of age, in an increase
in both parameters in each of the lesion groups. Both NE
3
concentration and
H-NE uptake in the cerebellum at 6 weeks
were not significantly different in any of the drug treat
ment groups.

Similarly in the pons-medulla, the values for
3

NE concentration and

H-NE uptake at six weeks were

significantly increased in the lesion groups.
18

However,
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Figure 1

Photomicrographs of histofluorescent fibers originating
in the locus coeruleus and traversing rostrally.

Sections

were taken from animals 7 days after birth, following either
a brainstem lesion at 3 days after birth (a) or anesthesia
only (b).

The bar in (a) indicates 50 tint*

Figure 2

Mean (+SEM) NE concentration (ng/g wet weight) and
rate of 3H-NE uptake (fmoles/mg protein/5 min) in the
cerebellum at six weeks after a neonatal midbrain lesion
and intraperitoneal treatment with a combination of saline/
morphine, and naloxone (group 1, N**6-ll).
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there was no significant difference in these parameters
among the drug treatment groups (fig. 3).
In the anterior and posterior cortex (figs. 4 and 5)
the lesion produced a dramatic decrease in the development
of NE concentration and ^H-NE uptake.

The different drug

treatments did not significantly alter either NE concentration or

H-NE uptake in any of the brain regions of animals

at 6 weeks after birth.

In Figure 6 the NE concentration

in the hippocampus is illustrated.

Within the lesioned

groups of animals there was a decrease in NE concentration
in the hippocampus similar to that seen in the cortical
areas.

Analysis of the Anova's on these measurements

established a significant main effect of the lesion in all
areas with all measurements, but there was no statistical
variance with the drug treatments.

Therefore, in all brain

regions studied the measurements for ^H-NE uptake and NE
concentration were significantly different between sham and
lesion animals, but within the sham and lesion groups the
values were not significantly different between the drug
treatment groups.
C.

Intraventricular Administration of Opioids
The values obtained for NE concentrations and rates
3

of

H-NE uptake of the animals as adults in group

reported in figures 7 - 1 4 .

2

are

In these animals that received

an injection of naloxone prior to an intraventricular
injection of an opioid (i.e. morphine or met-enkephalin),

Figure 3

Mean (+SEM) NE concentration (ng/g wet weight) in the
pons-medulla at six weeks after a neonatal midbrain lesion
and intraperitoneal treatment with a combination of saline,
morphine, and naloxone (group 1, N=6-12).
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Figure 4

Mean (+SEM) ME concentration (ng/g wet weight, N=6-12)
and rate of

H-NE uptake (fmoles/mg protein/5 min, N=4-7)

in the anterior cortex at six weeks after a neonatal
midbrain lesion and intraperitoneal treatment with a
combination of saline (sal), morphine (mor), and naloxone
{nalj (group 1).
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Figure 5

Mean (+SEM) ME concentration (ng/g wet weight) and
rate of

H-NE uptake (fmoles/mg protein/5 min) in posterior

cortex at six weeks after a neonatal midbrain lesion and
intraperitoneal treatment with a combination of saline
(sal)/ morphine (mor)/ and naloxone (nal) (group 1/ N=5-10).
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Figure 6

Mean (+SEM) NE concentration (ng/g wet weight) in the
hippocampus at six weeks after a neonatal midbrain lesion
and treatment with a combination of saline (sal), morphine
(mor), and naloxone (nal) (group 1, N=6-12).
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the midbrain lesion produced an increase in the NE concen
tration of the cerebellum (fig. 7) and pons-medulla (fig.
8).

This increase in NE concentration in the cerebellum

and pons-medulla was similar in all the drug treatment
groups.

The drug treatment groups in these areas all had

similar values for NE concentration in both the sham and
lesion animals.

In contrast the NE concentration in

anterior (fig. 9) and posterior (fig. 10) cortex and
hippocampus (fig. 11) was significantly lower in the groups
that received a lesion.
Similar results were obtained when

3
H-NE uptake was

studied in the different brain regions of lesioned animals.
In the anterior cortex (fig. 12) there was a significant
decrease in the rate of

3

H-NE uptake for those groups

receiving the cut, but there were no significant changes
with drug treatment.

The variability seen in these measure

ments is probably not reflective of drug treatment, but due
to smaller group size (N “ 3-5).

Similarly, in the

posterior cortex (fig. 13) the ^H-NE uptake was signifi
cantly lower in the lesion groups.

However there again

were no differences between the drug treatment groups.

In

the cerebellum (fig. 14), as in all areas previously report
ed, there was a significant effect of the lesion using
ANOVA for the ^H-NE uptake measurements, but the drug
treatments resulted in no statistical alterations.
In figure 15 NE is expressed as percent of control
for all the lesion animals in the different forebrain
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Figure 7

Mean (+SEM) NE concentration (ng/g wet weight) in the
cerebellum of 6 week old animals (group 2) after neonatal
injections of combinations of naloxone or saline plus
met-enkephalin (met-enk), or morphine, or saline in
unoperated sham controls (N=7-9) or animals that received
a neonatal brainstem lesion (N=10-12).

CEREBELLUM
Saline

h

M et-Enk
Morphine

H
Q sham

■>

H I LE SIO N

Naloxone
N aloxone+
—1
M et-E nk
N aloxone+
Morphine
•i

1------------------- 1—

250
NE (ng/g)

500

35

Figure 8

Mean (+SEM) NE concentration (ng/g wet weight) in the
pons-medulla of 6 week old animals (group

2)

after neonatal

injections of combinations of naloxone or saline plus metenkephalin (met-enk), or morphine, or saline in unoperated
sham controls (N»6-9) or animals that received a neonatal
brainstem lesion (N«*10-12).
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Figure 9

Mean (+SEM) ME concentration (ng/g wet weight) in the
anterior cortex of 6 week old animals (group 2) after
neonatal injections of combinations of naloxone or saline
plus met-enkephalin (met-enk), or morphine, or saline in
unoperated sham controls (Na7-9) or animals that received
a neonatal brainstem lesion (N=8-12).
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Figure 10

Mean (+SEM) NE concentration (ng/g wet weight) in the
posterior cortex of 6 week old animals (group 2) after
neonatal injections of combinations of naloxone (nal) or
saline (sal) plus met-enkephalin (met-enk), or morphine
(mor), or saline in unoperated sham controls (N=7-9) or
animals that received a neonatal brainstem lesion
(N*10-12).
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Figure 11

Mean (+SEMJ NE concentration (ng/g wet weight) in the
hippocampus of 6 week old animals (group 2) after neonatal
injections of combinations of naloxone (nal) or saline
(sal) plus met-enkephalin (met-enk)/ or morphine (mor)/ or
saline in unoperated sham controls (N=7-9) or animals that
received a neonatal brainstem lesion (Na9-ll).
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Figure 12

Mean (+SEM) rate of

3

H-NE uptake (fmoles/mg protein/

5 min) in the anterior cortex of 6 week old animals (group
2) after neonatal injections of combinations of naloxone
or saline plus met-enkephalin (met-enk), or morphine, or
saline in unoperated sham controls (N=3-7) or animals that
received a neonatal brainstem lesion (N=3-5).
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Figure 13

3

Mean (+SEM) rate of

H-NE uptake (fmoles/mg protein/

5 min) in the posterior cortex of 6 week old animals (group
2 ) after neonatal injections of combinations of naloxone
or saline plus met-enkephalin (met-enk), or morphine, or
saline in unoperated sham controls (N=4-8) or animals that
received a neonatal brainstem lesion (N=6-10). *
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Figure 14

Mean (+SEM) rate of ^H-NE uptake (fmoles/mg protein/
5 min) in the cerebellum of 6 week old animals (group 2)
after neonatal injections of combinations of naloxone
or saline plus met-enkephalin (met-enk), or morphine, or
saline in unoperated sham controls (N*4-8) or animals that
received a neonatal brainstem lesion (N=6-10).
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Figure 15

Mean NE concentration (ng/g wet weight# percent of
unoperated controls) in different forebrain areas of 6
week old animals that received a neonatal brainstem lesion
(N=61-63).

There is a significant difference {p <0*05)

between each region.
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regions.

The NE concentration of the lesloned animals In

the anterior cortex was 39% of the control animals, while
the posterior cortex was 27% of control, and significantly
different from that In the anterior cortex.

The lowest

content of NE was found in the hippocampus, at 21% of
control, and this was significantly different from that in
either area of the cortex.
D.

Met-Enkephalin Levels
There was no difference In met-enkephalin concen

tration, when expressed in terms of weight of the tissue,
between the lesion and the control animals at 1 and 4 days
after the lesion in any of the regions studied (table 2).
Table 3 represents an expression of the met-enkephalin
concentration per milligram of protein.

On this basis

there was a significant difference between the control and
lesloned animals in the locus coeruleus region 1 day after
the lesion.

At this time point the lesion group had higher

levels of met-enkephalin, but at 4 days after the lesion
there was no longer a difference between the groups.
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Days Ebst-lesion

Area
1 day
Control

4 days

Lesion

Control

Lesion

locus
Coeruleus
Region

165.76 ± 26.4* 190.65 ± 27.1 220.93 ± 41.7 258.64 ± 52.8

EbnsMedulla

412.83 ± 44.5

Posterior
Cortex

72.61 ± 3.9

425.88 ± 34.3 589.65 + 29.8 652.48 ± 54.7
61.42 ± 12.1

83.67 ± 5.1 118.16 ± 16.1

♦Mean ± SEM

Table 2
Met-enkephalin content (ng/mg tissue weight) in
various brain regions of rats, 1 and 4 days after a
dorsal bundle lesion made at 3 days after birth.
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Days Post-lesion

Area
1 day
Control

4 days
Lesion

Control

Lesion

locus
Coeruleus
Region

1.69 ± 0.34*

3.01 ± 0.34** 3.54 ± 0.48

EbnsMedulla

8.06 1 0.81

7.88 ± 0.68

11.36 i 0.36

12.36 ±1.13

Posterior
Cortex

1.72 ± 0.12

1.35 ± 0.27

1.67 ± 0.15

2.34 ± 0.29

3.09 ± 0.44

*Mean ± SEM
**p < 0.05

Table 3
Met-enkephalin concentration (ng/mg protein) in
various brain regions of rats, 1 and 4 days after a
dorsal bundle lesion made at 3 days after birth.

Chapter VI
Discussion
A.

Opioid Effects on Noradrenergic Neurons
Neonatal treatment with morphine# met-enkephalin, or

naloxone had no effect on NA fiber number in the brains of
sham control rats at six weeks after birth.

Within the

sham groups there was no difference between the assorted
drug treatments.

In the animals that received a DNB lesion,

there was also no difference among the drug treatment groups,
in NE concentration and 3H-NE uptake in the forebrain or

hindbrain regions.

The measurements of NE concentration

3

and

H-NE uptake taken together are a good indication of

NA nerve terminal density (Jonsson and Sachs, 1982).

The

surgical axotomy produced the expected increases in NA
fiber number in the brainstem and cerebellum, and decreases
in fiber number in the forebrain regions.
The previous findings, that morphine attenuated the NA
effects associated with a DNB lesion, implied that in the
present study the opioids would alter recovery of the NA
fibers.

Bardo et al. (1983) also found that morphine

administration with a midcollicular hemisection reduced
collateral sprouting in the ipsilateral cerebellar hemi
sphere, results similar to the preliminary study.

Earlier

studies with morphine and 6-0HD0PA, demonstrating that
morphine potentiated the effects of neonatal neurotoxin
treatment (Harston et al., 1981 and Jonsson and Hallman,
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1982a), also suggested an opioid Involvement In developmental
recovery.

Since recovery from neurotoxin and surgical

axotomy is very similar, morphine was expected to alter
the recovery from both manipulations.

Further support for

this hypothesis came from a report by Jonsson and Hallman
(1983), in which substance P administration after unilateral
transection of the DNB resulted in significant increases in
NA fiber number in the cerebellum and pons-*medulla.
Substance P in that study did not counteract the damage
in the cortex, but was effective in altering recovery of
NA fibers in some areas.
The results of the preliminary study are considered to
be unreliable, because of the large amount of variability
in the lesion groups.

The variability may have been the

result of inconsistent transection of the DNB neonatally.
If the lesion were not successful, the adult values
obtained would be identical to that of the controls
and thus inaccurately representing recovery.

In the

present study the surgical axotomy was considered to be
successful.

The ANOVAs on all the areas studied with all

the different treatments demonstrated a significant main
effect of the lesion.

Also, the large number of animals

surgically treated, has produced more consistent results.
Thus in this study the large variability within the lesion
groups was not present.

The success of the lesion was

verified in some animals by examining the fibers projecting
from the locus coeruleus four days after the lesion.

An

accumulation of NE was seen, indicating the fibers were
cut.

In these animals there was no visible clotting or

scarring at the lesion site.

Immunocytochemical locali

zation of glial fibrillary acidic protein, a

marker

for

glia, was used to study the glia after a neonatal brain
stem lesion.

An accumulation of the acidic protein

indicates scarring has taken place.

Examination of the

distribution of the glial fibrillary acidic protein in the
area of the lesion at six weeks revealed no accumulation
of this protein and thus no scarring {unpublished results).
Some of the values for NE content and

H-NE uptake, obtained

for the lesioned animals, were closer to control, and thus
suggested a degree of recovery of the NA fibers in these
animals.

Approximately one of eight surgically treated

animals demonstrated this recovery, possibly indicating a
percentage of unsuccessful cuts.

However, in the prelimi

nary study the frequency of these unusual animals may have
been greater than in the present study.
Bardo et al. (1983) found that morphine administration
with

a unilateral lesion of the DNB reduced the sprouting

in the ipsilateral cortex.
published completely.
available.

These results have never been

Thus the details of the study are not

This group used a unilateral lesion in their

study compared to a bilateral cut in the present study.
The conflicting results in the two studies could be
explained, if the lesion values obtained in the unilateral
study were compared to values obtained from the
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contralateral side rather than control animals.

Bardo et al.

(1983) also only mentioned effects in the cerebellum with no
information about the changes in the cortex.
Jonsson and Hallman (1983) also used a unilateral lesion
to show that substance P produced an alteration in nora
drenergic fiber recovery only in the hindbrain regions and
not in the cortical areas.

In the previous work with

neurotoxins, substance P could potentially modify recovery
of all of the projections of the locus coeruleus.

The

authors suggest that the substance P alterations may be
due to a growth-promoting effect of the compound in specific
areas and thus not a general effect on the locus coeruleus
to direct growth.
In contrast to those findings with neurotoxins, it is
now reported that opioids do not have an effect on recovery
of a NA system damaged by surgical axotomy.

Because opioids

do modify recovery of NA fibers damaged by the neurotoxin,
6-0HD0PA (Harston et al., 1981), the present study indicates
that this action probably results from a modification of the
neurotoxic actions of the 6-0HD0PA.

Failure of the opioids

to modify recovery of NA fibers from a mechanical lesion
suggests that the opioids are not capable of acting on the
NA fibers to actually stimulate regeneration.

Procedurally,

neurotoxins damage all major projections of the locus
coeruleus, by being taken up into the nerve terminal areas
and destroying these regions.

The surgical axotomy severs

the connections of the locus coeruleus to the forebrain
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projections only.

The DNB lesion severs the neurons in

only one major bundle.

Opioids may be effective in altering

nerve terminal input, but not in promoting major nerve fiber
connections.
Previous work in our laboratory has established that
neonatal 6-0HD0PA treatment (the same protocol as in the
neurotoxin studies) does not alter the number of cells in
the locus coeruleus (unpublished results).

In a similar

study with animals in which the DNB had been transected
neonatally, the number of cells in the locus coeruleus was
found to be decreased (Kostrzewa et al., 1985).

The damage

produced by transection of the DNB is thus very different
from the neurotoxin damage.
The evidence suggests that opioid alterations are
specific for neurotoxin induced damage.

This may be a

consequence of the opioids interacting with or combining
with 6-OHDOPA, although there is no evidence at present
for this.

The drugs are toxic to the neurons and the

opioids may also be toxic or just capable of enhancing the
toxicity of the neurotoxins.
The "pruning effect," proposed by Jonsson and Hallman
(1982a and b), suggests that nerve terminals are programmed
to develop a certain number of arborizations to each of the
target areas of the locus coeruleus.

Following damage to

one projection the neurons would develop an enhanced nerve
terminal arborization in an intact collateral region.

The

synaptic inputs onto the locus coeruleus were thought to
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influence this response to damage of the nuclei.

Exogenous

administration of opioids did not alter the response of the
nuclei to surgical axotomy; opioids, therefore, are not
working at the level of the perikarya, when altering the
recovery from neurotoxin damage.

The present study demon

strates that opioids do not alter true pruning, but rather
alter recovery from nerve terminal damage as in the
neurotoxin treated animals.
B.

Met-Enkephalin Concentration in Neonatal Animals with
a Severed Dorsal Noradrenergic Bundle
The animals that received the DNB lesion exhibited an

increase in met-enkephalin levels in the locus coeruleus
region, one day after the lesion.

This result could

indicate an increased met-enkephalin fiber activity, as a
consequence to NA fiber injury.

The effect was immediate,

but not prolonged, since met-enkephalin content was not
elevated four days after the lesion.

The validity of this

result is questionable, because an effect was not present
when the met-enkephalin concentration was expressed in
terms of tissue weight.
Additional studies would need to be done to clarify
these results.

Moreover, the locus coeruleus would need to

be more discretely dissected in order to obtain a greater
reliability of such findings.

Either biochemical measure

ments of met-enkephalin with micropunch samples would be
suitable, or immunocytochemical quantitative histochemistry
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of met-enkephalin fibers in the locus coeruleus.

More

frequent sampling would show the time course of any changes
in the met-enkephalin fibers resulting from NA fiber tran
section.

Although met-enkephalin levels may increase with

damage to the neurons, as indicated in this portion of the
study, exogenous administration of met-enkephalin did not
produce any apparent alteration in the recovery of locus
coeruleus fibers.
C.

Noradrenergic Recovery from a Dorsal Bundle Lesion
The DNB lesion was found to reduce NE content and

3

H-NE uptake in brain regions distal to the fiber transec
tion (i.e. neocortex and hippocampus).

At the same time a

retrograde degeneration occurs in at least a portion of
those fibers that were transected.

Upon studying the

recovery of the forebrain projections, it has been noted
that NA fiber recovery in the anterior cortex recovered to
a greater degree than was found in the posterior cortex.
Recovery was least in the hippocampus.
The pattern of recovery suggests that './A fiber
recovery is greater when axonal fiber length to a target
area is short.

A long axonal fiber length may result in

fewer axons being able to regenerate across the longer
fiber pathway.

Because the degree of recovery of NA fibers

was identical in each of the target regions at both 4 and 6
weeks, the recovery pattern appears to be permanent once
an animal reaches adulthood.
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Summary
Neither morphine nor met-enkephalin administration

alters the recovery of NA fibers in various rat brain regions
after a mechanical lesion of the DNB.

The opioid system does

not seem to play a role in regeneration of NA fibers after a
surgical lesion in the brainstem of developing animals.
Previous studies, using neurotoxins to produce damage,
suggested that the opioid system was capable of altering
the NA fiber development after damage to the system neo
natal ly.

The present studies indicate that the opioid

system does not have a growth promoting effect on NA
recovery from degeneration produced by a DNB cut, but that
the specific opioid compounds are only effective in
neurotoxin-indueed degeneration.
A regional difference in recovery of the NA fibers
after neonatal axonal transection has been noted.

The

present findings demonstrate that the degree of recovery
of central NA fibers is related to the length of the
axonal pathways.

The distance the terminal areas are from

the locus coeruleus seems to determine the amount of
recovery.
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